Artificial intelligence (AI) provider Lunit plans to go public in July with an initial public offering (IPO) of 1.1 million shares.
Lunit expects the shares will be offered in the range of $34 to $38 per share. The exact price will be determined after recording the demand of institutional investors on July 7-8. Retail buyers can take part in the public subscription during July 12-13, according to the vendor.
Lunit intends to list its common stock on the Korea Exchange's second bourse, KOSDAQ, under the ticker code "A32813." Based on the low end of the targeted range, Lunit expects to raise about $42 million. The company said it plans to spend the capital to finance global market development and research and development of its AI software.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
